-
Signature
-
/s/ Stephen Chen, as Attorney-in-Fact for Matthew Skaruppa
-
Stock symbol
-
DUOL
-
Transactions as of
-
Apr 3, 2023
-
Transactions value $
-
-$639,369
-
Form type
-
4
-
Date filed
-
4/4/2023, 04:24 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
DUOL |
Class A Common Stock |
Options Exercise |
$72.1K |
+5K |
+11.37% |
$14.42* |
49K |
Apr 3, 2023 |
Direct |
|
transaction |
DUOL |
Class A Common Stock |
Sale |
-$56.1K |
-400 |
-0.82% |
$140.34 |
48.6K |
Apr 3, 2023 |
Direct |
F1, F2 |
transaction |
DUOL |
Class A Common Stock |
Sale |
-$184K |
-1.3K |
-2.68% |
$141.91 |
47.3K |
Apr 3, 2023 |
Direct |
F1, F3 |
transaction |
DUOL |
Class A Common Stock |
Sale |
-$457K |
-3.2K |
-6.77% |
$142.66 |
44.1K |
Apr 3, 2023 |
Direct |
F1, F4 |
transaction |
DUOL |
Class A Common Stock |
Sale |
-$14.3K |
-100 |
-0.23% |
$143.36 |
44K |
Apr 3, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
DUOL |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5K |
-2.4% |
$0.00 |
203K |
Apr 3, 2023 |
Class A Common Stock |
5K |
$14.42 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: